INTA and QBPC sign cooperation agreement

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

INTA and QBPC sign cooperation agreement

INTA President Mei-lan Stark and Steven Wang, Acting Chairman of China’s Quality Brands Protection Committee, signed a cooperation agreement yesterday to deepen the collaboration between the two IP organizations. QBPC represents foreign brand owners in China and works to promote IP protection in the country.

signing-gu46678.jpg

Jack Chang, Honorary Chair of QBPC, said that the agreement with INTA marked a new page for the Committee. “We are the frontline soldiers fighting counterfeiting in China. The police kick the door down and we follow them in, and so we have in-depth experience of the tricks the counterfeiters play. We know the dos and don’ts, and how to engage the Chinese government. We won’t shy away from giving the Chinese government the credit it deserves, but we also have the courage to raise issues with officials.” But he added that it wasn’t enough to focus just on China in the fight against fakes. “We need to leverage the platform. INTA brings more international experience to QBPC.”

Stark said that the QBPC would help INTA to navigate China, and in return, the organization would help those brands that are not already global to become global.

more from across site and SHARED ros bottom lb

More from across our site

An Australian top court decision clarifying honest concurrent use and wins by publishers against AI platforms were also among the top talking points
AIPPI has pulled the plug on its planned 2027 World Congress, and INTA has delayed hosting a meeting there, but the concerns won’t abate
Despite being outspent by a wealthy opponent, a trial attorney at King & Spalding says ‘relentless pursuit of the truth’ helped his team secure a $420m damages award for mobile gaming client
190 drugs face loss of exclusivity between 2026 and 2030, with the list including Bristol Myers Squibb’s blood-thinning drug Eliquis and immunotherapy medication Opdivo
Nokia, represented by a team from Bird & Bird, adjudged to have made fair offer to Asus and Acer in UK SEP dispute
Azhar Sadique and Kane Ridley, who founded the London office in 2023, are now both working in legal tech and AI-related roles, while another UK-based lawyer has also left
Partner Pierre Pérot rejoins the firm he left in 2022 alongside another returning lawyer, associate Camille Abba
Vaping dispute, in which Stobbs and Brandsmiths are the representatives, tested how the UK's Human Rights Act can apply to injunctions restraining unjustified threats
An AI platform being sold for £40m, and lateral hires involving law firms Womble Bond Dickinson and Cadwell Thomas were among the top talking points
With the London Annual Meeting behind us, we look back at some of the lessons learned this week and ahead to what 2027 will bring
Gift this article